Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Prostate cancer3 trials
• Sarcoma3 trials
• Acute myeloid leukaemia1 trial
• Childhood cancers1 trial
• Kidney cancer1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting2 trials
• Terminated2 trials
• Not yet recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Italian Sarcoma Group4 trials
• Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS3 trials
• Eisai Inc.1 trial
• GlycoMimetics Incorporated1 trial
• IRCCS Azienda Ospedaliero-Universitaria di Bologna1 trial

Running trials

• Active, not recruiting

  Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms

  NCT06798805· IRCCS Azienda Ospedaliero-Universitaria di Bologna· Source

• Recruiting

  Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma

  NCT04383119· Phase 2· Italian Sarcoma Group· Source

  Contact: Valentina Fausti, MD

• Recruiting

  An Observational Study on Epithelioid Sarcoma

  NCT03099681· Italian Sarcoma Group· Source

  Contact: Lorella Gurreri, MD

• Active, not recruiting

  Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

  NCT02811861· Phase 3· Eisai Inc.· Source

• Recruiting

  Observational Study on Endometrial Stromal Tumors

  NCT02829437· Italian Sarcoma Group· Source

  Contact: Toni Ibrahim, MD (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Sarcoma2 recruiting
• Childhood cancers1 recruiting

Closed trials

• Completed

  Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)

  NCT03454750· Phase 2· Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS· Source

• Withdrawn

  Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin

  NCT03773510· Phase 3· Italian Sarcoma Group· Source

• Terminated

  Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia

  NCT03616470· Phase 3· GlycoMimetics Incorporated· Source

• Terminated

  Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging.

  NCT03465579· Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS· Source

• Completed

  Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors

  NCT03453528· Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS· Source